Chi Meng Fong
Stock Analyst at Bank of America Securities
(0.78)
# 3,885
Out of 4,421 analysts
39
Total ratings
37.5%
Success rate
-10.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chi Meng Fong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Maintained: Buy | $21 | $15.88 | +32.24% | 4 | Jun 2, 2026 | |
| ROIV Roivant Sciences | Maintained: Hold | $30 → $32 | $31.43 | +0.22% | 24 | May 25, 2026 | |
| AMPH Amphastar Pharmaceuticals | Reiterated: Hold | $25 | $18.81 | +32.91% | 1 | May 7, 2026 | |
| CCCC C4 Therapeutics | Rated: Hold | n/a | $4.15 | n/a | 5 | Oct 31, 2023 | |
| FHTX Foghorn Therapeutics | Rated: Hold | n/a | $4.15 | n/a | 5 | Oct 6, 2023 |
Relay Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $21
Current: $15.88
Upside: +32.24%
Roivant Sciences
May 25, 2026
Maintained: Hold
Price Target: $30 → $32
Current: $31.43
Upside: +0.22%
Amphastar Pharmaceuticals
May 7, 2026
Reiterated: Hold
Price Target: $25
Current: $18.81
Upside: +32.91%
C4 Therapeutics
Oct 31, 2023
Rated: Hold
Price Target: n/a
Current: $4.15
Upside: n/a
Foghorn Therapeutics
Oct 6, 2023
Rated: Hold
Price Target: n/a
Current: $4.15
Upside: n/a